Melanoma and the Hippo pathway

Lead researcher

Dr Mark Shackleton, A/Prof Kieran Harvey

Institution

Research Division, Peter MacCallum Cancer Centre

Years funded

2015-2017

Discovering new treatments for different types of human cancer is essential. We have identified the Hippo tumor suppressor signaling pathway as a potential new avenue by which melanoma, the deadliest form of skin cancer, could be treated. Using highly efficient laboratory modelling of human melanoma, we will test whether targeting the Hippo pathway could treat this disease. Our findings will have the potential to influence treatment of other cancers too.

Funding Body

Cancer Council Research Grant

Funding

$100,000 per annum

Updated: